z-logo
Premium
Hepatic cytoprotection by prostaglandins: Theories unlimited
Author(s) -
Levine Robert A.
Publication year - 1988
Publication title -
hepatology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.488
H-Index - 361
eISSN - 1527-3350
pISSN - 0270-9139
DOI - 10.1002/hep.1840080443
Subject(s) - cytoprotection , medicine , biology , endocrinology , immunology , oxidative stress
16,16 Dimethyl prostaglandin E 2 (dmPGE 2 ), a known cytoprotective agent, was examined for its ability to alter the course of fulminant hepatitis in an experimental model of fulminant viral hepatitis, murine hepatitis virus type 3 (MHV‐3). Fully susceptible BALB/cJ mice, infected with 100 50% lethal doses (LD 50 ) of MHV‐3 developed histologic and biochemical evidence of fulminant hepatitis, as evidenced by massive hepatic necrosis with hypoglycemia, metabolic acidosis, and a markedly elevated serum alanine aminotransferase (ALT) (mean, 1,402 ± 619 IU/liter). In contrast, animals treated with dmPGE 2 either before or after infection (up to 48 h) demonstrated a marked reduction in both histologic and biochemical evidence of liver damage as characterized by normal blood glucose, total CO 2 , and ALT determinations (mean ALT, 63 ± 40 IU/liter). Treatment of infected mice with PGF 2 demonstrated no cytoprotective effects. High titers of infectious virus were recovered from the livers of both dmPGE 2 ‐treated and ‐untreated animals throughout the course of infection. In a parallel in vitro study, dmPGE 2 (10 −4 –10 −8 M) demonstrated a similar cytoprotective effect on monolayers of isolated cultured hepatocytes from fully susceptible BALB/cJ mice infected at a multiplicity of infection of 0.1, 1.0, and 10.0. In addition, splenic macrophages recovered from infected and untreated BALB/cJ mice demonstrated a marked augmentation in procoagulant activity (PCA) from a basal 10 ± 5 mU/10 6 splenic macrophages to a maximum of 615 ± 102 mU/10 6 splenic macrophages, whereas no increase in macrophage PCA was detected in infected animals treated with dmPGE 2 . These results suggest that dmPGE 2 , without detectably altering viral replication or infectivity in vivo , confers a marked cytoprotective effect on hepatocytes both in vivo and in vitro , and prevents the induction of macrophage PCA in vivo in fully susceptible BALB/cJ mice after murine hepatitis virus type 3 infection.

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom